US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Research & Development Market Research Reports & Industry Analysis

The term research and development (R&D) refers to work that is done in order to better understand the nature, function or understanding of a topic or product in order to gain knowledge and find new applications for existing products or to develop new and innovative products. This is usually performed by corporations, government agencies, and research or academic institutions.

New product design and development is essential for the survival and growth of many companies, as markets and consumers’ tastes are fickle and the competition can be fierce. In order to stay relevant in a fast changing marketplace, firms have to constantly revise and expand their range of product offerings. Therefore, research and development is of great economic importance as companies fight to maintain their market share, though it may mean forgoing current profits in favor of potential future performance and returns.

Research and development is most often associated with the technology industry, as well as with science and in particular with healthcare and the development of new pharmaceuticals, diagnostics or medical devices that are safe and effective. For instance, drug makers must constantly search for the next big blockbuster drug, since the products they currently have on the market will eventually lose their patent protection and be vulnerable to generic competition. So they spend huge amounts of money on R&D because without a promising drug pipeline their revenue stream will ultimately dry up.

RSS Feeds

Research & Development Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Pharmaceutical Industry Business Outlook and Procurement Report H1 2016
4/29/2016 | published by: Kable
... operational efficiency. China, India, and Brazil are the leading emerging markets that are expected to offer the most opportunities for global pharmaceutical industry growth in H1 2016. Market uncertainty and rising competition are the immediate ...  |  read more...
USD 1,950
Global Hypertension Drugs Market 2016-2020
4/13/2016 | published by: TechNavio - Infiniti Research Ltd.
... Systemic hypertension (commonly referred to as hypertension) PAH, high BP in the arteries that carry blood from the heart to the lungs, occurs when blood vessels narrow, making blood flow difficult. This creates pressure on ...  |  read more...
USD 2,500
Global Womens Health Market 2016-2020
4/12/2016 | published by: TechNavio - Infiniti Research Ltd.
... that affect women such as HIV/AIDS, endometriosis, infertility, polycystic ovary syndrome, postmenopausal osteoporosis, and cancer (primarily ovarian and breast cancer). It also includes issues other than the biological conditions, like gender inequality (women are sometimes ...  |  read more...
USD 2,500
Global Orphan Diseases Partnering 2010-2016: Deal trends, players and financials
4/1/2016 | published by: Current Partnering
... for headline, upfront and royalty by stage of development Orphan Diseases partnering agreement structure Orphan Diseases partnering contract documents Top Orphan Diseases deals by value Most active Orphan Diseases dealmakers Most of the deals included ...  |  read more...
USD 2,995
Global Migraine Partnering 2010 to 2016
4/1/2016 | published by: Current Partnering
... Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides ...  |  read more...
USD 1,495
Global Biotherapeutics Industry 2016 Market Research Report
3/18/2016 | published by: 9Dimen Research
... the main countries (United States, Germany, Japan and China). The report firstly introduced the Biotherapeutics basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so ...  |  read more...
USD 2,850
Global Immunotherapy Drugs 2016-2020
3/29/2016 | published by: TechNavio - Infiniti Research Ltd.
... diseases such as cancer, respiratory, infectious, and autoimmune disorders. Technavio’s analysts forecast the global immunotherapy drugs market to grow at a CAGR of 11.52% during the period 2016-2020. Covered in this report The report covers ...  |  read more...
USD 2,500
Alzheimer’s Disease - Pipeline Review, H1 2016
3/16/2016 | published by: Global Markets Direct
... therapeutics under development for Alzheimer’s Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,500
Biotechnology in the US - Industry Market Research Report
3/23/2016 | published by: IBISWorld
... an aging population. Although the industry has grown, a consolidation trend has emerged as large pharmaceutical makers have increasingly targeted industry firms for acquisition, to expand their product portfolios ahead of impending patent expirations. Continued ...  |  read more...
USD 1,020
Diagnostic Breakthroughs for Neurodegenerative Diseases (TechVision)
3/30/2016 | published by: Frost & Sullivan
... present across the global neurodiagnostic industry have been covered under neurobiomarkers, neuroimaging and neuroinformatics segments. While providing brief overviews for each technology, the research service also covers industrial snapshots and emerging innovations in the neurodiagnostic ...  |  read more...
USD 4,950
Conference Documentation: Superbugs & Superdrugs - Pushing financial incentives and collaborative incentives to accelerate clinical success
3/17/2016 | published by: SMI Publishing, Ltd
... as microbes are becoming more resistant and fewer drugs are passing clinical trials successfully. Moreover, the increase in global migration accelerates the spread as we have seen from Mers and Ebola viruses, as well as ...  |  read more...
USD 788.78
Emerging Pharmaceuticals Markets in China
4/1/2016 | published by: Asia Market Information & Development Company
... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ...  |  read more...
USD 4,000
Global Dental Partnering 2010-2016: Deal trends, players and financials
4/1/2016 | published by: Current Partnering
... and royalty by stage of development Dental partnering agreement structure Dental partnering contract documents Top Dental deals by value Most active Dental dealmakers Most of the deals included within the report occur when a licensee ...  |  read more...
USD 2,995
Blepharitis - Pipeline Review, H1 2016
3/16/2016 | published by: Global Markets Direct
... for Blepharitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ...  |  read more...
USD 2,000
Medical & Scientific Research (GLOBAL) - Industry Report
3/1/2016 | published by: Plimsoll Publishing Ltd.
... DEVELOPPEMENT, TSENKI and TEXAS INSTRUMENTS FRANCE. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Medical & Scientific Research (GLOBAL) analysis is ideal for anyone ...  |  read more...
USD 1,480
Medical & Scientific Research (EUROPEAN) - Industry Report
3/1/2016 | published by: Plimsoll Publishing Ltd.
... RESOURCES LIMITED, JOINT - STOCK COMPANY ACADEMICIAN M.F. RESHETNEV INFORMATION SATELLITE SYSTEMS and STAGO INTERNATIONAL. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Medical ...  |  read more...
USD 1,240
Nerve Injury - Pipeline Review, H1 2016
2/24/2016 | published by: Global Markets Direct
... therapeutics under development for Nerve Injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Primary Biliary Cirrhosis - Pipeline Review, H1 2016
2/24/2016 | published by: Global Markets Direct
... information on the therapeutics under development for Primary Biliary Cirrhosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the ...  |  read more...
USD 2,000
Dementia - Pipeline Review, H1 2016
2/29/2016 | published by: Global Markets Direct
... for Dementia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ...  |  read more...
USD 2,000
Scientific Research and Development (R&D) Industry, in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs) Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2022, NAIC 541711
2/12/2016 | published by: Plunkett Research, Ltd.
... benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Scientific Research and Development (R&D) Industry, in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs) Industry (U.S.) to reach ...  |  read more...
USD 1,995
Scientific Research and Development (R&D) Industry, in Telecommunications, Computers, Physical Sciences, Medical Devices and Pharmaceuticals Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2022, NAIC 541700
2/12/2016 | published by: Plunkett Research, Ltd.
... benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Scientific Research and Development (R&D) Industry, in Telecommunications, Computers, Physical Sciences, Medical Devices and Pharmaceuticals Industry (U.S.) to reach ...  |  read more...
USD 1,995
Lymphoma Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... cancer. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 141 drugs. Lymphoma Drug Pipeline Update lists all drugs and gives you a ...  |  read more...
USD 6,750
Antibodies in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... the second wave in the lucrative field of therapeutic antibodies. There are today 527 companies plus partners developing 1187 antibody drugs in 2733 developmental projects in cancer. In addition, there are 5 suspended drugs and ...  |  read more...
USD 6,750
Immunotherapy in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... antibodies, vaccines, and immunostimulators in oncology drug development into one source. There are today 789 companies plus partners developing 1432 cancer immunotherapy drugs in 3604 developmental projects in cancer. In addition, there are 18 suspended ...  |  read more...
USD 11,025
Hematological Cancers Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... hematological cancer drugs in 2306 developmental projects in cancer. In addition, there are 10 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 299 drugs. Hematological Cancers Drug ...  |  read more...
USD 8,850
< prev 1    3  4  5  6  7  8  9  10